UV LED therapy shows promise in preventing focal seizures
Researchers from the Medical School at the University of Minnesota (Minneapolis/St. Paul, MN) discovered that light from a UV-emitting LED reduced "seizure-like" activity in a rat epilepsy model.1 As a result, the researchers are optimistic that an LED-based implantable device could be created to reduce the effects of epilepsy while avoiding harmful effects of conventional treatments.
In the study, UV light released gamma aminobutyric acid (GABA) from the "caged" compound carbonyl amino butanoic acid (BC204). GABA then decreased the abnormal electrical activity in the CA1 area of the brain. Results of this study have considerable potential in treating focal epilepsy in humans.
When conventional treatment doesn't work
Focal (or partial) epilepsy is very common in both adults and can occur in children. It is caused by an abnormality in a localized area of the brain resulting from such conditions as stroke, trauma, or infections. Up to one-third of epileptic patients fail to respond to conventional medical therapies and are subject to toxic effects from antiepileptic drugs. While surgery has benefited some patients with focal epilepsy, many patients do not experience a complete remission after operation, prompting researchers to investigate alternative treatments.
Steven Rothman and colleagues conducted experiments with UV LEDs to control seizure-like activity in rodent brain slices. Population spikes in CA1 (which reflect the discharge of a population of neurons) were elicited by delivering constant current pulses through a microelectrode placed in the CA3 brain area. Researchers induced seizure-like activity by adding the convulsant, 4-aminopyridine (4-AP; 100 µM) and removing magnesium from the fluid solution outside the cells. Caged GABA, BC204, was perfused into the preparation for at least 30 minutes prior to the first illumination.
When population spikes were measured (as a reflection of tissue excitability), the research team found that illumination of control slices by a UV LED driven by a current of up to 200 mA had no effect on peak amplitudes. Addition of BC204 (30 µM) and illumination using as little as 50 mA LED current produced a statistically significant reduction of the peak of the population spike. More important, BC204 (10 µM) significantly reduced the slice spikes and bursting induced by the 4-AP and low magnesium.
Avoiding toxic doses of medication
"Our strongly positive results, in an epilepsy model far more severe than the naturally occurring disease, suggest that this technique could translate to human epilepsy," said Rothman. Researchers believe that a programmable pump could deliver the caged GABA into the subarachnoid space over the epileptic area of the brain. UV LEDs could then be responsively activated to release GABA, using techniques similar to those used for cortical stimulation units that are currently in clinical trials.
"Optical stimulation would be a far more rapid delivery method than any mechanical device for direct administration of drug into the brain and would not subject patients to toxic doses of medication or irreversible brain damage from epilepsy resections," added Rothman.
REFERENCE:
1. Xiao-Feng Yang et al., "Optical suppression of experimental seizures in rat brain slices." Epilepsia; Published Online: August 2009 (DOI: 10.1111/j.1528-1167.2009.02252.x); Print Issue Date: January 2010. http://www3.interscience.wiley.com/journal/122541827/abstract
John Wallace | Senior Technical Editor (1998-2022)
John Wallace was with Laser Focus World for nearly 25 years, retiring in late June 2022. He obtained a bachelor's degree in mechanical engineering and physics at Rutgers University and a master's in optical engineering at the University of Rochester. Before becoming an editor, John worked as an engineer at RCA, Exxon, Eastman Kodak, and GCA Corporation.